Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Adachi, J.D.

Search results

  • RSS Feed
(1 - 8 of 8)
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Adachi, J.D.; Bone, H.G.; Daizadeh, N.S.; Dakin, P.; Papapoulos, S.; Hadji, P.; ... ; Ferrari, S. 2017
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Article / Letter to editor
metadata only
Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study
Modi, A.; Sen, S.; Adachi, J.D.; Adami, S.; Cortet, B.; Cooper, A.L.; ... ; MUSIC-OS Study Grp 2016
Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study
Article / Letter to editor
metadata only
Evolution of subject characteristics in FREEDOM and its extension for up to 8 years
Adachi, J.D.; Lin, C.J.F.; Bolognese, M.A.; Hadji, P.; Papapoulos, S.; Recknor, C.; ... ; Hassall, J. 2015
Evolution of subject characteristics in FREEDOM and its extension for up to 8 years
Article / Letter to editor
metadata only
Changes in Subject Characteristics in the Denosumab Pivotal Fracture Trial and Its Extension for up to 8 Years
Adachi, J.D.; Lin, C.J.F.; Ho, P.R.; Bolognese, M.A.; Bone, H.G.; Hadji, P.; ... ; Ferrari, S. 2014
Changes in Subject Characteristics in the Denosumab Pivotal Fracture Trial and Its Extension for up to 8 Years
Article / Letter to editor
metadata only
Low incidence of fracture maintained with long-term denosumab treatment in women aged >= 75 years with postmenopausal osteoporosis
Papapoulos, S.; McClung, M.R.; Ranchimont, N.; Adachi, J.D.; Bone, H.G.; Benhamou, C.L.; ... ; Boonen, S. 2013
Low incidence of fracture maintained with long-term denosumab treatment in women aged >= 75 years with postmenopausal osteoporosis
Article / Letter to editor
metadata only
DENOSUMAB (DMAB) TREATMENT FOR 6 YEARS MAINTAINS LOW FRACTURE INCIDENCE IN WOMEN >= 75 YEARS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO)
Papapoulos, S.; Mcclung, M.R.; Franchimont, N.; Adachi, J.D.; Bone, H.G.; Benhamou, C.L.; ... ; Boonen, S. 2013
DENOSUMAB (DMAB) TREATMENT FOR 6 YEARS MAINTAINS LOW FRACTURE INCIDENCE IN WOMEN >= 75 YEARS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO)
Article / Letter to editor
metadata only
Management of Glucocorticoid-Induced Osteoporosis
Rizzoli, R.; Adachi, J.D.; Cooper, C.; Dere, W.; Devogelaer, J.P.; Diez-Perez, A.; ... ; Reginster, J.Y. 2012
Management of Glucocorticoid-Induced Osteoporosis
Article / Letter to editor
metadata only
Low Fracture Incidence Is Maintained in Postmenopausal Women >= 75 Years with Osteoporosis with Long-Term Denosumab Treatment
Papapoulos, S.; McClung, M.R.; Franchimont, N.; Adachi, J.D.; Bone, H.G.; Benhamou, C.L.; ... ; Boonen, S. 2012
Low Fracture Incidence Is Maintained in Postmenopausal Women >= 75 Years with Osteoporosis with Long-Term Denosumab Treatment
Article / Letter to editor
metadata only